# Dose-Finding Study of E7070 in Combination With Irinotecan

> **NCT00060567** · PHASE1 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 88 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** E7070 + irinotecan combination
- **DRUG:** Irinotecan + E7070 combination
- **DRUG:** Irinotecan + E7070 combination

## Key facts

- **NCT ID:** NCT00060567
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2023-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00060567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00060567, "Dose-Finding Study of E7070 in Combination With Irinotecan". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00060567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*